Go to the list of all blogs
Scott Bell's Avatar
published in Blogs
Nov 04, 2026
TickeronGET DAILY SIGNALS
VEA vs VGK: Weighing Broad Developed Markets Exposure Against a Europe Focus

VEA vs VGK: Weighing Broad Developed Markets Exposure Against a Europe Focus

Key Takeaways

  • VEA tracks the FTSE Developed All Cap ex US Index and holds roughly 3,900 stocks across Japan, Canada, Europe, and Australia, while VGK tracks the FTSE Developed Europe All Cap Index and holds about 1,230 developed European stocks.
  • Both funds are passively managed, market-capitalization-weighted index vehicles, but VEA offers materially broader geographic diversification, while VGK is a concentrated Europe-only tilt.
  • Cost structure favors VEA, which carries a 0.03% expense ratio versus 0.06% for VGK, a meaningful difference for long-term holders.
  • Sector overlap is significant, with financials and industrials dominating both portfolios; VGK adds a larger healthcare weight and higher single-stock concentration, led by ASML Holding at roughly 4.4% of assets.
  • Relative positioning diverges by macro driver: VEA layers in Japan/Korea semiconductor and Canadian exposure, while VGK leans on European banks, pharmaceuticals, and capital goods.
  • Tickeron AI Verdict: VEA — its broader diversification, lower cost, and multi-region exposure give it the structural edge over the Europe-focused VGK.

Why These ETFs Matter for International Exposure

VEA and VGK rank among the more popular choices for investors seeking equity exposure outside the United States. They are not interchangeable, however. VGK functions essentially as a regional subset of the wider universe covered by VEA. The former delivers a core allocation to developed markets ex-U.S., while the latter isolates developed European equities. Deciding between them comes down to questions of breadth versus focus, diversification versus concentration, and overall cost efficiency.

VEA: Broad Developed Markets Exposure

VEA is a passively managed ETF designed to track the FTSE Developed All Cap ex US Index. This market-capitalization-weighted benchmark includes large-, mid-, and small-cap stocks from developed markets outside the United States. The fund maintains approximately 3,900 holdings, placing it among the broadest options in the international developed-equity space. Japan, the United Kingdom, and Canada represent the largest country weights, with Europe accounting for roughly half of assets and the Pacific region about one-third. Top holdings remain modest in size, with names such as Samsung Electronics, SK Hynix, ASML Holding, HSBC Holdings, Roche Holding, Royal Bank of Canada, Novartis, AstraZeneca, Nestlé, and Shell each staying below roughly 2.5% of assets. Financials lead the sector allocation at approximately 24%, followed by industrials and technology. The expense ratio stands at 0.03%. I also checked this using Tickeron’s AI Screener to see how the fund compares with peers on cost and holdings metrics.

VGK: A Focused Europe Play

VGK tracks the FTSE Developed Europe All Cap Index and holds roughly 1,230 securities across large-, mid-, and small-cap European companies. The United Kingdom, Switzerland, France, and Germany form the largest country exposures, followed by the Netherlands, Spain, Sweden, and Italy. Concentration is higher here, with ASML Holding comprising about 4.4% of assets. Other notable positions include HSBC Holdings, Roche Holding, Novartis, Nestlé, Shell, Siemens, AstraZeneca, SAP, and Banco Santander. Financials again lead at around 25%, with industrials near 19% and healthcare near 12%. The expense ratio is 0.06%.

Market Backdrop and Key Drivers

Both ETFs sit within the developed international equity category, where recent cycles have reflected easing monetary policy expectations alongside still-elevated interest rates that have supported bank profitability. Artificial intelligence and semiconductor demand have benefited technology holdings, including Asia-based names in VEA and ASML in both funds. Europe-specific factors such as defense spending, energy transition investment, and pharmaceutical innovation also play a role, while Japan’s corporate governance reforms add a distinct element captured only by VEA. Risks include regional slowdowns, currency movements, and geopolitical developments.

Performance, Risk, and Positioning

Both funds have participated in the recent recovery in developed international equities, though their drivers differ. VEA has benefited from exposure to Japanese and Korean semiconductor leaders as well as Canadian holdings. VGK has drawn more from European banks, pharmaceuticals, and capital goods, with ASML as its largest single influence. VEA’s wider holdings base generally supports lower idiosyncratic risk, whereas VGK’s narrower mandate increases sensitivity to European-specific developments. Investors seeking a diversified core allocation have often leaned toward VEA, while those preferring a deliberate Europe overweight may favor VGK.

Refining ETF Comparisons with AI Tools

When comparing funds like these, I find it helpful to run additional screens for technical patterns, fundamentals, and volatility metrics. Tickeron’s AI Screener lets me apply customizable filters across thousands of ETFs and stocks to highlight differences in holdings concentration, sector weights, and performance characteristics that might otherwise take considerable manual effort to surface.

Tickeron AI Verdict

Based on structural characteristics, the AI-assisted view favors VEA over VGK at present. VEA combines a lower expense ratio, far broader diversification across nearly 3,900 holdings, and multi-region exposure that captures semiconductor and financials momentum across Asia and Europe while limiting single-stock and single-country risk. VGK remains suitable for a targeted Europe allocation, yet its higher concentration and narrower scope bring greater sensitivity to regional outcomes. On a risk-adjusted and cost-adjusted basis, VEA’s breadth and efficiency currently appear the more durable choice.

Disclaimer

The information on this webpage is provided for general informational and educational purposes only and is not intended as investment advice, a recommendation to purchase or sell any security, or an offer or solicitation related to investments. It does not consider your personal financial situation, goals, or risk profile, and all investing carries inherent risks, including the possibility of losing your entire investment. For more details, please review our full disclaimer.

Disclaimers and Limitations

Related Ticker: VEA, VGK

Contributor

Scott Bell's AvatarScott Bell|Expert

I’m a trader and independent researcher. My interest lies at the intersection of financial markets, algorithms, and capital management. I develop data-driven tools and strategies and study algorithmic approaches to market analysis. I help turn complex market data into clear insights and practical systems. I believe technology should support, not replace, investment thinking


VEA's MACD Histogram just turned positive

The Moving Average Convergence Divergence (MACD) for VEA turned positive on October 27, 2026. Looking at past instances where VEA's MACD turned positive, the stock continued to rise in 39 of 44 cases over the following month. The odds of a continued upward trend are 89%.

Price Prediction Chart

Technical Analysis (Indicators)

Bullish Trend Analysis

Following a +0.84% 3-day Advance, the price is estimated to grow further. Considering data from situations where VEA advanced for three days, in 266 of 329 cases, the price rose further within the following month. The odds of a continued upward trend are 81%.

Bearish Trend Analysis

The Stochastic Oscillator may be shifting from an upward trend to a downward trend. In 53 of 58 cases where VEA's Stochastic Oscillator exited the overbought zone, the price fell further within the following month. The odds of a continued downward trend are 90%.

The Momentum Indicator moved below the 0 level on November 03, 2026. You may want to consider selling the stock, shorting the stock, or exploring put options on VEA as a result. In 69 of 78 cases where the Momentum Indicator fell below 0, the stock fell further within the subsequent month. The odds of a continued downward trend are 88%.

Following a 3-day decline, the stock is projected to fall further. Considering past instances where VEA declined for three days, the price rose further in 50 of 62 cases within the following month. The odds of a continued downward trend are 80%.

The Aroon Indicator for VEA entered a downward trend on November 03, 2026. This could indicate a strong downward move is ahead for the stock. Traders may want to consider selling the stock or buying put options.

Notable companies

The most notable companies in this group are Shopify Inc (NASDAQ:SHOP), SSR Mining (NASDAQ:SSRM).

Industry description

The investment seeks to track the performance of the FTSE Developed All Cap ex U.S. Index. The fund employs an indexing investment approach designed to track the performance of the FTSE Developed All Cap ex U.S. Index, a market-capitalization-weighted index that is made up of approximately 3,957 common stocks of large-, mid-, and small-cap companies located in Canada and the major markets of Europe and the Pacific region. The Advisor attempts to replicate the target index by investing all, or substantially all, of its assets in the stocks that make up the index, holding each stock in approximately the same proportion as its weighting in the index.

Market Cap

The average market capitalization across the Vanguard FTSE Developed Markets ETF (VEA) ETF is 30.05B. The market cap for tickers in the group ranges from 449.15M to 183.44B. SHOP holds the highest valuation in this group at 183.44B. The lowest valued company is PERI at 449.15M.

High and low price notable news

The average weekly price growth across all stocks in the Vanguard FTSE Developed Markets ETF (VEA) ETF was -1%. For the same ETF, the average monthly price growth was -2%, and the average quarterly price growth was 0%. PERI experienced the highest price growth at 32%, while SHOP experienced the biggest fall at -14%.

Volume

The average weekly volume growth across all stocks in the Vanguard FTSE Developed Markets ETF (VEA) ETF was -6%. For the same stocks of the ETF, the average monthly volume growth was -1% and the average quarterly volume growth was -31%

Fundamental Analysis Ratings

The average fundamental analysis ratings, where 1 is best and 100 is worst, are as follows

Valuation Rating: 56
P/E Growth Rating: 58
Price Growth Rating: 52
SMR Rating: 63
Profit Risk Rating: 66
Seasonality Score: 13 (-100 ... +100)
View a ticker or compare two or three
Interact to see
Advertisement
A.I.Advisor
published price charts
A.I. Advisor
published General Information

General Information

Category ForeignLargeBlend

Category
Foreign Large Blend
Address
Vanguard Tax-managed FundsPo Box 2600Valley Forge
Phone
N/A
Web
www.vanguard.com
Interact to see
Advertisement
The Bitwise Solana Staking ETF (BSOL) advanced roughly 18% over the trailing 30 days, closely tracking a sharp rally in Solana (SOL). The move extends a broader recovery, with BSOL up approximately 77% over the past three months from its mid-2026 trough.
MSTY is an actively managed single-stock option income ETF (exchange-traded fund) that writes call options on Strategy (MSTR), formerly MicroStrategy, to generate current income. The portfolio is anchored by U.S. Treasury bills and MSTR option contracts rather than a diversified basket of equities, concentrating exposure in one volatile underlying.
AMDL has surged roughly +64% over the past 30 days, from about $47.59 to $78.10, mirroring a powerful rally in its sole underlying stock, AMD . The fund is a leveraged single-stock ETF (exchange-traded fund) designed to deliver 2x the daily return of AMD, amplifying both gains and losses.
Shares of CBZ are declining approximately 13.00% on Thursday, April 30, 2026, falling from a prior close of approximately $36.30 to approximately $31.60, as the initial post-earnings enthusiasm that drove the stock sharply higher on April 29 gives way to a "sell the news" reversal once investors process the deeper detail of Q1 2026 results
Shares of CHH are declining approximately 13.00% on Thursday, April 30, 2026, falling from a prior close of $117.36 to approximately $102.10, as Q1 2026 earnings released after Wednesday's close delivered a severe adjusted EPS miss of $1.07 against the $1.32 analyst consensus — an 18.9% shortfall — while net income collapsed 54.4% year-over-year to $20.3 million from $44.5 million, confirming the worst fears of investors regarding the company's near-term profitability trajectory.
VEA vs VGK: Weighing Broad Developed Markets Exposure Against a Europe Focus